MedPath
HSA Approval

ABRAD FILM COATED TABLET 5 MG

SIN17057P

ABRAD FILM COATED TABLET 5 MG

ABRAD FILM COATED TABLET 5 MG

July 31, 2024

LOTUS INTERNATIONAL PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantLOTUS INTERNATIONAL PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

C01EB17

Manufacturer Information

LOTUS INTERNATIONAL PTE. LTD.

Genepharm S.A.

Active Ingredients

Ivabradine HCl eqv. Ivabradine

5 mg

Ivabradine

Documents

Package Inserts

Abrad Tablet PI.pdf

Approved: July 31, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ABRAD FILM COATED TABLET 5 MG - HSA Approval | MedPath